China CAS:17183-98-1 Manufacturer

August 2022
Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
99% manufactures meets the requirements of GMP.
Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

Please feel free to reach out to us for more information on product details.

CPHI China will be staged at Shanghai New International Expo Center on June 24-26, 2025 together with ICSE & PMEC China,our booth number is W1G20(b).

I've spent over twenty years working with companies like yours, and if there's one question I hear more than any other, it's this one. Selecting the right intermediates can feel like a high-stakes puzzle, where one wrong piece can impact your entire production line. It’s a decision that goes beyond mere cost; it's about partnership, reliability, and the integrity of your final product. In my journey, I've seen how a strategic partnership with a focused manufacturer like Humanwell Pharmaceutical can transform this challenging task from a source of anxiety into a competitive advantage. Let's break down the critical parameters you need to consider.